PRX-102 More Effective than Fabrazyme to Treat Kidney Function in Fabry Patients, Trial Results Show
The investigative therapy pegunigalsidase alfa (PRX-102) effectively stabilized kidney function in Fabry disease patients more efficiently than Fabrazyme,…